Amersham Health launched analytical software designed to help practitioners better identify, measure, and manage costs associated with myocardial perfusion imaging studies on Jan. 8. MPOptions models economic factors affecting office-based and outpatient
Amersham Health launched analytical software designed to help practitioners better identify, measure, and manage costs associated with myocardial perfusion imaging studies on Jan. 8. MPOptions models economic factors affecting office-based and outpatient imaging centers and provides what-if scenarios to explore alternatives for delivering nuclear cardiology services efficiently and cost-effectively. The software calculates costs in several categories, including labor, capital equipment, facility, pharmaceutical, and supplies. MPOptions was developed with Amersham funding by physicians at Cardiovascular Consultants in St. Louis and Georgetown University in Washington, DC.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.